Adjuvant chemotherapy did not improve gallbladder cancer prognosis
نویسندگان
چکیده
منابع مشابه
Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma
Background Abnormal expression of Stathmin 1(STMN1) plays an important role in the proliferation and migration of gallbladder carcinoma (GBC). The purpose of current study is to investigate the prognostic significance of STMN1 in GBC patients after surgery. Methods STMN1 expression was evaluated with immunohistochemistry (IHC) on tissue microarrays from 70 GBC patients from a single instituti...
متن کاملWhether or not to give adjuvant chemotherapy for breast cancer.
There is no longer any reasonable doubt that adjuvant chemotherapy prolongs survival for premenopausal women with early breast cancer. Indeed, in more than 100 years of research into breast cancer management it is the first form of treatment convincingly shown to have survival benefit. Yet important questions linger over its real clinical value. These include the balance of benefit against morb...
متن کاملAdjuvant Chemotherapy of Colorectal Cancer.
Advances have been made in the adjuvant therapy of colorectal cancers. Fluorouracil-based chemotherapy has now been demonstrated to improve long-term disease-free survival rates in patients with resected stage III colon cancer. Combined radiation therapy plus fluorouracil-based chemotherapy has been shown to improve both local control and disease-free survival in patients with stage II and III ...
متن کاملAdjuvant Chemotherapy for Endometrial Cancer
The prognosis of early-stage endometrial cancer is favorable, even when treated using surgery alone, whereas recurrent cases or advanced cases (stage III or IV) with progression beyond the uterus have a poor prognosis1), and therapy for such cancers is still in the exploratory stages. Stage I and II cases are sometimes treated with adjuvant therapy to prevent recurrence after surgical therapy; ...
متن کاملAdjuvant chemotherapy for rectal cancer.
Adjuvant chemotherapy for rectal cancer In a recently published review of randomised trials, we called into question the widely held view that patients with rectal cancer who are treated with preoperative chemoradiotherapy should routinely receive further postoperative adjuvant 5-fluorouracil (5-FU)-based chemotherapy [1]. The aim of this letter was to present additional relevant data that have...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: HPB
سال: 2019
ISSN: 1365-182X
DOI: 10.1016/j.hpb.2019.10.083